UNI-rhIL-11 (Uni-Bio)

N/A

Report date: 2024/03/22 16:27:14

Base Information

Drug NameUNI-rhIL-11 (Uni-Bio)
Drug Alias Name重组人白介素11（联康生物科技集团）Recombinant human interleukin 11 (Uni-Bio)rhIL-11 (Uni-Bio)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin 11 receptor alpha stimulants
TargetsInterleukin 11 receptor alpha
Therapy Area/IndicationsThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUni-Bio Science Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUni-Bio Science Group
Active IndicationsN/A
Inactive IndicationsThrombocytopenia

Other Information

ATC CodeN/A
Related LinksN/A